![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
13 min
![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
How Effective Are Obesity Medications for Reducing Hepatic Decompensation in NASH? Evidence-Based GI: An ACG Publication and Podcast
-
- Médecine
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Sonali Paul, MD discuss “Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events among Patients with Type 2 Diabetes Mellitus: A Scandinavian Cohort Study,” Engstom A, Wintzell V, Melbye M, et al. Hepatology 2024; In Press.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Sonali Paul, MD discuss “Association of Glucagon-Like Peptide-1 Receptor Agonists with Serious Liver Events among Patients with Type 2 Diabetes Mellitus: A Scandinavian Cohort Study,” Engstom A, Wintzell V, Melbye M, et al. Hepatology 2024; In Press.
13 min